SPAC

5 trends in biotech dealmaking to watch in 2021
5 trends in biotech dealmaking to watch in 2021
BioPharma Dive
biotech
Neuroscience
SPAC
Big Pharma
private equity
Flag link:
Biotech Investors Rolling the Dice with 250% SPAC Surge
Biotech Investors Rolling the Dice with 250% SPAC Surge
BioSpace
biotech
SPAC
Flag link:
Pfizer Spinoff Cerevel Therapeutics Begins Trading on the Nasdaq
Pfizer Spinoff Cerevel Therapeutics Begins Trading on the Nasdaq
BioSpace
Pfizer
Cerevel Therapeutics
SPAC
Arya Sciences
NASDAQ
Flag link:
David Hung’s Nuvation Bio seals merger with blank check firm Panacea
David Hung’s Nuvation Bio seals merger with blank check firm Panacea
Pharmaforum
Nuvation Bio
David Hung
cancer
Panacea
SPAC
Flag link:
Four biotechs and a Matthew Roden-led SPAC price IPOs, raising a combined $528M
Four biotechs and a Matthew Roden-led SPAC price IPOs, raising a combined $528M
Endpoints
IPOs
biotech
SPAC
Matthew Roden
Praxis Precision Medicines
Tarsus Pharmaceuticals
Aligos Therapeutics
Kiromic Biopharma
Tumeric Acquisition
Flag link:
It’s Raining Biotech SPACs!
It’s Raining Biotech SPACs!
Forbes
biotech
SPAC
IPOs
Flag link:
A second Carl Icahn protégé jumps in on SPAC spree, as Alex Denner guns for $175M
A second Carl Icahn protégé jumps in on SPAC spree, as Alex Denner guns for $175M
Endpoints
SPAC
Sarissa Capital
Flag link:
More biotechs test the third way to market
More biotechs test the third way to market
EP Vantage
biotech
SPAC
IPOs
Flag link:
Blank check company merger creates cancer specialist Vincera
Blank check company merger creates cancer specialist Vincera
Pharmaforum
SPAC
Vincera
LifeSci Acquisition
oncology
cancer
Bayer
Flag link:
Vesper Healthcare Acquisition, a SPAC led by the former CEO of Allergan, files for a $400 million IPO
Vesper Healthcare Acquisition, a SPAC led by the former CEO of Allergan, files for a $400 million IPO
NASDAQ
Vesper Healthcare Acquisition
Brent Saunders
Allergan
SPAC
IPOs
Flag link:
Karuna and Incyte scrap programs; More cash for the SPACs
Karuna and Incyte scrap programs; More cash for the SPACs
Endpoints
Karuna Therapeutics
Eli Lilly
Incyte
SPAC
Flag link:
Pfizer spinoff Cerevel to raise $445M in merger with blank-check company
Pfizer spinoff Cerevel to raise $445M in merger with blank-check company
BioPharma Dive
Cerevel Therapeutics
Pfizer
M&A
SPAC
special purpose acquisition company
Flag link:
Why Some Biotech Companies Are Turning to SPACs
Why Some Biotech Companies Are Turning to SPACs
Motley Fool
biotech
SPAC
special purpose acquisition company
IPOs
Therapeutics Acquisition
Flag link: